AGP Picks
View all

French Guiana Wellness Network
Provided by AGP

French Guiana Wellness Network: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on French Guiana Wellness Network.

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

September 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30

October 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Press releases published on October 15, 2026

Mobia Medical to Report Third Quarter 2026 Financial Results on November 5, 2026
Oct. 15, 2026

Mobia Medical to Report Third Quarter 2026 Financial Results on November 5, 2026

Indeterminate GlobeNewswire
Spero Therapeutics to Participate in the Chardan 10th Annual Healthcare Conference
Oct. 15, 2026

Spero Therapeutics to Participate in the Chardan 10th Annual Healthcare Conference

Indeterminate GlobeNewswire
Myriad Genetics to Release Third Quarter 2026 Financial Results on November 4, 2026
Oct. 15, 2026

Myriad Genetics to Release Third Quarter 2026 Financial Results on November 4, 2026

Indeterminate GlobeNewswire
LB Pharmaceuticals to Participate in Upcoming Investor Events
Oct. 15, 2026

LB Pharmaceuticals to Participate in Upcoming Investor Events

Indeterminate GlobeNewswire
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
Oct. 15, 2026

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
MacroGenics Announces First Patient Dosed in Phase 1 Study of MGC030 in Patients with Advanced Solid Tumors
Oct. 15, 2026

MacroGenics Announces First Patient Dosed in Phase 1 Study of MGC030 in Patients with Advanced Solid Tumors

Indeterminate GlobeNewswire
Syndax’s Revuforj® (revumenib) Named to TIME’s Best Inventions of 2026 List
Oct. 15, 2026

Syndax’s Revuforj® (revumenib) Named to TIME’s Best Inventions of 2026 List

Indeterminate GlobeNewswire
MDxHealth Announces Preliminary Third Quarter 2026 Revenue and Suspends Full-Year 2026 Revenue Guidance
Oct. 15, 2026

MDxHealth Announces Preliminary Third Quarter 2026 Revenue and Suspends Full-Year 2026 Revenue Guidance

Indeterminate GlobeNewswire
Opus Genetics Presents Positive Clinical Data from OPGx-BEST1 and OPGx-LCA5 Gene Therapy Programs at Retina in Rio 2026
Oct. 15, 2026

Opus Genetics Presents Positive Clinical Data from OPGx-BEST1 and OPGx-LCA5 Gene Therapy Programs at Retina in Rio 2026

Indeterminate GlobeNewswire
Anavex Receives FDA Clearance of its IND Application for Blarcamesine in Fragile X Syndrome
Oct. 15, 2026

Anavex Receives FDA Clearance of its IND Application for Blarcamesine in Fragile X Syndrome

Indeterminate GlobeNewswire
Ten Reputable Micro Indentation Tester Manufacturers 2026: Advancing Precision Material Mechanical Testing
Oct. 15, 2026

Ten Reputable Micro Indentation Tester Manufacturers 2026: Advancing Precision Material Mechanical Testing

Indeterminate EIN Presswire
Avance Clinical to Showcase its Early Phase Center of Excellence Model at AusBiotech International 2026
Oct. 15, 2026

Avance Clinical to Showcase its Early Phase Center of Excellence Model at AusBiotech International 2026

Indeterminate GlobeNewswire
Grupo Bimbo Achieves 98% Positive Nutrition Across Its Daily Consumption Portfolio
Oct. 15, 2026

Grupo Bimbo Achieves 98% Positive Nutrition Across Its Daily Consumption Portfolio

Indeterminate GlobeNewswire
Booking Health Announces Medical Records Review, Specialist Second Opinions and Treatment Coordination for Pancreatic Cancer Patients Seeking Care in Germany
Oct. 15, 2026

Booking Health Announces Medical Records Review, Specialist Second Opinions and Treatment Coordination for Pancreatic Cancer Patients Seeking Care in Germany

Indeterminate GlobeNewswire
Mab Designs announces publication of C20, a selective inhibitor of IL-6 trans-signalling, in Nature's Communications Biology
Oct. 15, 2026

Mab Designs announces publication of C20, a selective inhibitor of IL-6 trans-signalling, in Nature's Communications Biology

Indeterminate GlobeNewswire
Major Alzheimer’s prevention trial testing single and combo therapy assigns first participant
Oct. 15, 2026

Major Alzheimer’s prevention trial testing single and combo therapy assigns first participant

Indeterminate GlobeNewswire
VIP Plastic Surgery Designated an Accredited Medical Tourism Institution by South Korea’s Ministry of Justice
Oct. 15, 2026

VIP Plastic Surgery Designated an Accredited Medical Tourism Institution by South Korea’s Ministry of Justice

Indeterminate GlobeNewswire
Oxford Healthspan Launches Primeadine® GF Spermidine Powder, Expanding Its Gluten-Free Line
Oct. 15, 2026

Oxford Healthspan Launches Primeadine® GF Spermidine Powder, Expanding Its Gluten-Free Line

Indeterminate GlobeNewswire
Affidea unterzeichnet einen Vertrag zur Übernahme von zwei Alliance Medical-Zentren im Zentrum von London und beschleunigt damit sein Wachstum in Großbritannien
Oct. 15, 2026

Affidea unterzeichnet einen Vertrag zur Übernahme von zwei Alliance Medical-Zentren im Zentrum von London und beschleunigt damit sein Wachstum in Großbritannien

Indeterminate GlobeNewswire
Affidea signe un accord en vue d’acquérir deux centres Alliance Medical dans le centre de Londres, accélérant ainsi sa croissance au Royaume-Uni
Oct. 15, 2026

Affidea signe un accord en vue d’acquérir deux centres Alliance Medical dans le centre de Londres, accélérant ainsi sa croissance au Royaume-Uni

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

French Guiana Wellness Network

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.